Trial Outcomes & Findings for Comparing 6-Minute Walk Tests for Ambulatory Oxygen Assessment (NCT NCT05630092)

NCT ID: NCT05630092

Last Updated: 2026-04-20

Results Overview

Continuous monitoring of SpO2 will allow for the measurement in the drop from baseline to the lowest point (nadir) during the test. Between the walk tests, the average drop will be calculated and compared.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

93 participants

Primary outcome timeframe

During the walk test

Results posted on

2026-04-20

Participant Flow

Participant milestones

Participant milestones
Measure
Maximal Then Normal Speed Walk Test
Maximal speed walking test (Max\_6MWT) followed by normal speed walking test (Nor\_6MWT). Maximal 6-minute Walk Test (Max\_6MWT): Instructions given to perform the walk test following the international guidelines using the phrase 'as far as you can'. Normal speed 6-minute Walk Test (Nor\_6MWT): Instructions given to perform the walk test following the international guidelines except using the phrase 'at a speed you would normally walk'.
Normal Then Maximal Speed Walk Test
Normal speed walking test (Nor\_6MWT) followed by Maximal speed walking test (Max\_6MWT) Maximal 6-minute Walk Test (Max\_6MWT): Instructions given to perform the walk test following the international guidelines using the phrase 'as far as you can'. Normal speed 6-minute Walk Test (Nor\_6MWT): Instructions given to perform the walk test following the international guidelines except using the phrase 'at a speed you would normally walk'.
Overall Study
STARTED
48
45
Overall Study
COMPLETED
45
37
Overall Study
NOT COMPLETED
3
8

Reasons for withdrawal

Reasons for withdrawal
Measure
Maximal Then Normal Speed Walk Test
Maximal speed walking test (Max\_6MWT) followed by normal speed walking test (Nor\_6MWT). Maximal 6-minute Walk Test (Max\_6MWT): Instructions given to perform the walk test following the international guidelines using the phrase 'as far as you can'. Normal speed 6-minute Walk Test (Nor\_6MWT): Instructions given to perform the walk test following the international guidelines except using the phrase 'at a speed you would normally walk'.
Normal Then Maximal Speed Walk Test
Normal speed walking test (Nor\_6MWT) followed by Maximal speed walking test (Max\_6MWT) Maximal 6-minute Walk Test (Max\_6MWT): Instructions given to perform the walk test following the international guidelines using the phrase 'as far as you can'. Normal speed 6-minute Walk Test (Nor\_6MWT): Instructions given to perform the walk test following the international guidelines except using the phrase 'at a speed you would normally walk'.
Overall Study
Protocol Violation
3
8

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Group 1 (M-N)
n=45 Participants
Maximal speed walking test (Max\_6MWT) followed by normal speed walking test (Nor\_6MWT). Maximal 6-minute Walk Test (Max\_6MWT): Instructions given to perform the walk test following the international guidelines using the phrase 'as far as you can'. Normal speed 6-minute Walk Test (Nor\_6MWT): Instructions given to perform the walk test following the international guidelines except using the phrase 'at a speed you would normally walk'.
Group 2 (N-M)
n=37 Participants
Normal speed walking test (Nor\_6MWT) followed by Maximal speed walking test (Max\_6MWT) Maximal 6-minute Walk Test (Max\_6MWT): Instructions given to perform the walk test following the international guidelines using the phrase 'as far as you can'. Normal speed 6-minute Walk Test (Nor\_6MWT): Instructions given to perform the walk test following the international guidelines except using the phrase 'at a speed you would normally walk'.
Total
n=82 Participants
Total of all reporting groups
Age, Continuous
69.36 Years
STANDARD_DEVIATION 11.09 • n=45 Participants
68.24 Years
STANDARD_DEVIATION 10.97 • n=37 Participants
68.85 Years
STANDARD_DEVIATION 10.98 • n=82 Participants
Sex: Female, Male
Female
17 Participants
n=45 Participants
10 Participants
n=37 Participants
27 Participants
n=82 Participants
Sex: Female, Male
Male
28 Participants
n=45 Participants
27 Participants
n=37 Participants
55 Participants
n=82 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
Region of Enrollment
United Kingdom
45 participants
n=45 Participants
37 participants
n=37 Participants
82 participants
n=82 Participants
Primary Respiratory Diagnosis
Asthma
1 Participants
n=45 Participants
1 Participants
n=37 Participants
2 Participants
n=82 Participants
Primary Respiratory Diagnosis
COPD
16 Participants
n=45 Participants
12 Participants
n=37 Participants
28 Participants
n=82 Participants
Primary Respiratory Diagnosis
ILD
22 Participants
n=45 Participants
15 Participants
n=37 Participants
37 Participants
n=82 Participants
Primary Respiratory Diagnosis
SOBOE
3 Participants
n=45 Participants
2 Participants
n=37 Participants
5 Participants
n=82 Participants
Primary Respiratory Diagnosis
Other
3 Participants
n=45 Participants
7 Participants
n=37 Participants
10 Participants
n=82 Participants

PRIMARY outcome

Timeframe: During the walk test

Population: All participants that successfully completed both tests were used in the final analysis, comparing the changes over each test type.

Continuous monitoring of SpO2 will allow for the measurement in the drop from baseline to the lowest point (nadir) during the test. Between the walk tests, the average drop will be calculated and compared.

Outcome measures

Outcome measures
Measure
Max_6MWT
n=82 Participants
Maximal 6-minute Walk Test (Max\_6MWT): Instructions given to perform the walk test following the international guidelines using the phrase 'as far as you can'.
Nor_6MWT
n=82 Participants
Normal speed 6-minute Walk Test (Nor\_6MWT): Instructions given to perform the walk test following the international guidelines except using the phrase 'at a speed you would normally walk'.
Average Drop in SpO2 From Baseline to Nadir
6 SpO2 (%)
Interval 5.0 to 7.0
5 SpO2 (%)
Interval 4.0 to 6.0

SECONDARY outcome

Timeframe: During the walk test

Population: All participants that successfully completed both tests were used in the final analysis, comparing the changes over each test type.

The time from the start of the test and the lowest (nadir) SpO2 will be recorded and compared between the walk tests.

Outcome measures

Outcome measures
Measure
Max_6MWT
n=82 Participants
Maximal 6-minute Walk Test (Max\_6MWT): Instructions given to perform the walk test following the international guidelines using the phrase 'as far as you can'.
Nor_6MWT
n=82 Participants
Normal speed 6-minute Walk Test (Nor\_6MWT): Instructions given to perform the walk test following the international guidelines except using the phrase 'at a speed you would normally walk'.
Is There a Difference in the Time Taken to Reach Nadir in SpO2?
150 Seconds
Interval 120.0 to 170.0
150 Seconds
Interval 140.0 to 160.0

SECONDARY outcome

Timeframe: During the walk test

Population: All participants that successfully completed both tests were used in the final analysis, comparing the changes over each test type.

The absolute lowest (nadir) in SpO2 (%) recorded during the test will be recorded and compared.

Outcome measures

Outcome measures
Measure
Max_6MWT
n=82 Participants
Maximal 6-minute Walk Test (Max\_6MWT): Instructions given to perform the walk test following the international guidelines using the phrase 'as far as you can'.
Nor_6MWT
n=82 Participants
Normal speed 6-minute Walk Test (Nor\_6MWT): Instructions given to perform the walk test following the international guidelines except using the phrase 'at a speed you would normally walk'.
Is There a Difference in the Nadir SpO2 (%) Between Maximal and Normal Walking Speed?
88.41 SpO2 (%)
95% Confidence Interval 4.883 • Interval 87.34 to 89.43
88.98 SpO2 (%)
95% Confidence Interval 4.385 • Interval 88.01 to 89.94

OTHER_PRE_SPECIFIED outcome

Timeframe: During the walk test

Population: All participants that successfully completed both tests were used in the final analysis, comparing the changes over each test type.

Measurement of the time taken to reach nadir in SpO2 will be recorded to help justify the length of the walk test

Outcome measures

Outcome measures
Measure
Max_6MWT
n=82 Participants
Maximal 6-minute Walk Test (Max\_6MWT): Instructions given to perform the walk test following the international guidelines using the phrase 'as far as you can'.
Nor_6MWT
n=82 Participants
Normal speed 6-minute Walk Test (Nor\_6MWT): Instructions given to perform the walk test following the international guidelines except using the phrase 'at a speed you would normally walk'.
At What Time Does the Nadir in SpO2 Occur During a Nor_6MWT
150 Seconds
Interval 90.0 to 210.0
150 Seconds
Interval 90.0 to 210.0

Adverse Events

Max_6MWT

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Nor_6MWT

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Deputy Lead Respiratory and Sleep Physiologist

Hampshire Hospitals NHS Foundation Trust

Phone: 01962824101

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place